Medical device pioneer Creo Medical has outlined how it will prioritise developing pioneering technology that meets the urgent needs created by Covid-19, including sterilisation of PPE and medical equipment.

Insider Media reports the company has welcomed Welsh Secretary Simon Hart to its site where he heard how Creo will use a £2m investment to develop its Cool Plasma technology, which has been shown to be effective in inactivating and decontaminating Covid-19.

The £2m loan, repayable over five years, has been provided by the Cardiff Capital Region.

Simon Hart was also shown Creo’s range of advanced energy surgical endoscopy products. Products that are already being used to revolutionise bowel cancer treatment and could soon be used to treat other forms of cancer, such as lung and pancreatic cancer.

Creo chief executive Craig Gulliford said “We were very pleased to welcome the secretary of state for Wales to our facilities here in Chepstow.

“We are proud to have taken our expertise in developing innovative medical devices and applied them to our plasma technology to develop products that could help halt the spread of coronavirus.

“Wales has a strong reputation for producing technology rich and innovative life sciences companies and I am delighted we have established a platform to develop critical medical tools here in the UK that will benefit cancer patients worldwide, and to protect our nation against a resurgence of Covid-19.”

Simon Hart said “It is fantastic to see Welsh companies stepping up to the challenges created by this pandemic and developing technology that can make a real difference in the fight against Covid-19. The Cardiff Capital Region’s £2m investment will boost the innovative research that is already taking place at Creo Medical and help to cement South Wales’ position as a world leader in the development of medical technology.”